Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: How do they differ from those in seasonal influenza?

Journal of Infectious Diseases

Volumn 203, Issue 12, 2011, Pages 1739-1747

  Lee, Nelson ^a,b   Chan, Paul K S ^b   Lui, Grace C Y ^a   Wong, Bonnie C K ^a   Sin, Winnie W Y ^b   Choi, Kin Wing ^b   Wong, Rity Y K ^a   Lee, Elaine L Y ^b   Yeung, Apple C M ^b   Ngai, Karry L K ^b   Chan, Martin C W ^a   Lai, Raymond W M ^b   Yu, Alex W Y ^b   Hui, David S C ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL SUPERINFECTION; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL PATIENT; HUMAN; IMMUNOFLUORESCENCE; INTENSIVE CARE UNIT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SURVIVAL RATE; VIRUS CULTURE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL AGENTS; CHINA; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PANDEMICS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS; SEASONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79957444119     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir187     Document Type: Article

References (48)

1. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708-19.
2. Centers for Disease Control and Prevention (CDC). H1N1 flu. Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009 - April 10, 2010. Available at: http://www.cdc.gov/ h1n1flu/estimates-2009-h1n1.htm. Accessed 31 May 2010.
3. World Health Organization. Pandemic (H1N1) 2009 - update 94, 2010. Available at: http://www.who.int/csr/don/2010-04-01/en/index.html. Accessed 15 August 2010.
4. Carcione D, Giele C, Dowse GK, et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis 2010; 16:1388-95.
5. Tang JW, Tambyah PA, Lai FY, et al. Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med 2010; 170:861-7.
6. Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-84.
7. Belongia EA, Irving SA, Waring SC, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010; 304:1091-8.
8. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 374:2072-9.
9. Zarychanski R, Stuart TL, Kumar A, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182:257-64.
10. Campbell A, Rodin R, Kropp R, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010; 182:349-55.
11. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-44.
12. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880-7.
13. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-902.
14. Webb SA, Pettila V, Seppelt I, et al. The ANZIC influenza investigators: critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361:1925-34.
15. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010; 38(Suppl 4):e91-7.
16. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic H1N1 Influenza in Pregnancy Working Group. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303:1517-25.
17. Lee EH, Wu C, Lee EU, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010; 50:1498-504.
18. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:1-52.
19. Lee N, Choi KW, Chan PK, et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010; 65:510-5.
20. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45:1568-75. (Pubitemid 351411840)
21. Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infect Control Hosp Epidemiol 2010; 31:676-82.
22. Chang YS, van Hal SJ, Spencer PM, Gosbell IB, Collett PW. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust 2010; 192:90-3.
23. Lee N, Chan PKS, Wong CK, et al. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther 2011; 16:237-47.
24. Riquelme R, Torres A, Rioseco ML, et al. Influenzapneumonia: a comparison between seasonal influenza virus and H1N1 pandemic. Eur Respir J 2010. Epub ahead of print. Jan 27. doi: 10.1183/09031936.00125910.
25. Hospital Authority, Hong Kong SAR. Interim guideline on antiviral treatment, chemoprophylaxis and pneumococcal vaccination for human swine influenza H1N1. Available at: http://www.ha.org.hk/visitor/ha-visitor-index.asp? Parent-ID5138537&Content-ID5138667. Accessed 1 March 2010.
26. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1003-32.
27. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2):S27-72.
28. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200:492-500.
29. Lam WY, Leung TF, Lee N, et al. Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus. J Med Virol 2010; 82:675-83.
30. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: nited Kingdom first wave (May-September 2009). Influenza Clinical Information Network (FLU-CIN). Thorax 2010; 65:645-51.
31. Wong CM, Yang L, Chan KP, et al. Influenza-associated hospitalization in a subtropical city. PLoS Med 2006; 3:e121.
32. Wu JT, Ma ES, Lee CK, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010; 51:1184-91.
33. Ganzenmueller T, Kluba J, Hilfrich B, et al. Comparison of the performance of direct fluorescent antibody staining, a point-of-care rapid antigen test and virus isolation with that of RT-PCR for the detection of novel 2009 influenza A (H1N1) virus in respiratory specimens. J Med Microbiol 2010; 59:713-7.
34. Yang P, Deng Y, Pang X, et al. Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect 2010; 61:277-83.
35. van den Brand JM, Stittelaar KJ, van Amerongen G, et al. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis 2010; 201:993-9.
36. Agrati C, Gioia C, Lalle E, et al. Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course. J Infect Dis 2010; 202:681-9.
37. To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010; 50:850-9.
38. Dalton CB, Cretikos MA, Durrheim DN, Seppelt IM, Rawlinson WD, Dwyer DE. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust 2010; 192:357-8: author reply 357.
39. Kumar D, Michaels MG, Morris MI, et al. American Society of Transplantation H1N1 Collaborative Study Group. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521-6.
40. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009; 4:e6051.
41. Adisasmito W, Chan PK, Lee N, et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis 2010; 202:1154-60.
42. Li CC, Wang L, Eng HL, et al. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis 2010; 16:1265-72.
43. Giannella M, Alonso M, Garcia de Viedma D, et al. Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect 2010. doi: 10.1111/j.1469-0691.2010.03399.x.
44. Cheng AC, Dwyer DE, Kotsimbos AT, et al. Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents. Med J Aust 2009; 191:142-5.
45. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-70.
46. McCullers JA. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J Infect Dis 2004; 190:519-26. (Pubitemid 38982091)
47. McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA. PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 2010; 6:e1001014.
48. Dao CN, Kamimoto L, Nowell M, et al. Emerging Infections Program Network. Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States. J Infect Dis 2010; 202:881-8.